# FGF6

## Overview
FGF6, or fibroblast growth factor 6, is a gene that encodes a protein belonging to the fibroblast growth factor family, which is known for its involvement in a variety of biological processes, including cell growth, development, and tissue repair. The FGF6 protein is particularly significant in the context of skeletal muscle regeneration, where it plays a crucial role in the repair and differentiation of muscle cells. It primarily interacts with the FGFR4 receptor, facilitating signaling pathways that are essential for muscle cell function and regeneration (Nies2016Fibroblast). Additionally, FGF6 is involved in cellular processes such as proliferation and survival through pathways like MAPK, PI3K, and PLCγ (Farooq2021The). Beyond its role in muscle biology, FGF6 has been implicated in various clinical conditions, including iron metabolism disorders and cancer, where its expression levels and interactions can influence disease progression and pathology (Xie2020FGF/FGFR; Guo2019A).

## Function
FGF6 (fibroblast growth factor 6) is a member of the FGF family, which plays a significant role in muscle regeneration and development. FGF6 is specifically associated with skeletal muscle regeneration and is restricted to the myogenic lineage. In FGF6-deficient mice, severe skeletal muscle regeneration defects are observed, characterized by fibrosis and myotube degeneration, indicating its crucial role in muscle repair processes (Nies2016Fibroblast).

FGF6 primarily signals through the FGFR4 receptor, which is highly expressed during myoblast differentiation and in recently formed myotubes. This signaling is essential for the proper differentiation and function of muscle cells (Nies2016Fibroblast). In adult skeletal muscle tissue, FGFR1 is expressed at moderate levels, suggesting that FGF6 may also interact with this receptor, although its primary interaction is with FGFR4 (Nies2016Fibroblast).

FGF6 is involved in various cellular processes, including cell proliferation, differentiation, and survival, through its interaction with FGFRs and activation of intracellular signaling pathways such as MAPK, PI3K, and PLCγ (Farooq2021The). These pathways are crucial for the regulation of cellular behaviors necessary for tissue repair and regeneration.

## Clinical Significance
FGF6 has been implicated in several diseases and conditions due to mutations, altered expression levels, or changes in its interactions. In the context of iron metabolism, FGF6 is associated with hemochromatosis, a condition characterized by excessive iron accumulation. Variants of FGF6, such as E172X, D174V, and R188Q, have been shown to disrupt iron homeostasis by altering hepcidin expression and intracellular iron concentration, suggesting a role in conditions like anemia of chronic disease and systemic sclerosis (Guo2019A).

In cancer, FGF6 expression is notably altered in liver carcinoma. It is decreased in non-metastatic liver cancer tissues but increased in metastatic tissues, indicating a potential role in cancer progression and metastasis (Xie2020FGF/FGFR; Goutam2023Exploring). This differential expression suggests that FGF6 may contribute to tumorigenesis and metastasis in liver cancer.

FGF6 is also involved in muscle regeneration, and its deficiency can lead to impaired muscle repair. FGF6 knockout mice exhibit defective muscle regeneration and increased fibrosis, highlighting its importance in muscle healing processes (Xie2020FGF/FGFR; Beenken2009The). These findings underscore the clinical significance of FGF6 in both iron metabolism disorders and cancer.

## Interactions
FGF6 interacts with various proteins and nucleic acids, playing a significant role in cellular signaling pathways. In skeletal muscle, FGF6 overexpression leads to increased phosphorylation of proteins involved in the mTOR signaling pathway, such as 4EBP1 and P70S6K, which are downstream effectors of mTOR. This interaction enhances protein synthesis and muscle hypertrophy by stimulating the phosphorylation of AKT and ERK1/2, known activators of mTOR (Xu2021Skeletal).

FGF6 also influences the expression of genes related to muscle growth and atrophy. It suppresses atrophy-related genes like Mstn, Murf1, Fbxo32, and Fbxo21, while upregulating hypertrophy-related genes such as Igf1, Fst-total, Fst288, and Fst315. This regulation is associated with a reduction in circulating myostatin levels, a protein that inhibits muscle growth (Xu2021Skeletal).

In adipose tissue, FGF6, along with FGF9, activates UCP1 expression through FGFR3, independent of the traditional brown adipogenesis pathway. This process involves the production of PGE2 and the recruitment of transcriptional co-activators like FLII and LRRFIP1, which interact with ERRA to enhance UCP1 transcription (Shamsi2020FGF6). These interactions highlight FGF6's role in regulating energy metabolism and thermogenesis.


## References


[1. (Guo2019A) Shicheng Guo, Shuai Jiang, Narendranath Epperla, Yanyun Ma, Mehdi Maadooliat, Zhan Ye, Brent Olson, Minghua Wang, Terrie Kitchner, Jeffrey Joyce, Peng An, Fudi Wang, Robert Strenn, Joseph J. Mazza, Jennifer K. Meece, Wenyu Wu, Li Jin, Judith A. Smith, Jiucun Wang, and Steven J. Schrodi. A gene-based recessive diplotype exome scan discovers fgf6, a novel hepcidin-regulating iron-metabolism gene. Blood, 133(17):1888–1898, April 2019. URL: http://dx.doi.org/10.1182/blood-2018-10-879585, doi:10.1182/blood-2018-10-879585. This article has 13 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood-2018-10-879585)

[2. (Xu2021Skeletal) Bo Xu, Caizhi Liu, Hong Zhang, Rong Zhang, Mengyang Tang, Yan Huang, Li Jin, Lingyan Xu, Cheng Hu, and Weiping Jia. Skeletal muscle–targeted delivery of fgf6 protects mice from diet-induced obesity and insulin resistance. JCI Insight, October 2021. URL: http://dx.doi.org/10.1172/jci.insight.149969, doi:10.1172/jci.insight.149969. This article has 11 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1172/jci.insight.149969)

[3. (Beenken2009The) Andrew Beenken and Moosa Mohammadi. The fgf family: biology, pathophysiology and therapy. Nature Reviews Drug Discovery, 8(3):235–253, March 2009. URL: http://dx.doi.org/10.1038/nrd2792, doi:10.1038/nrd2792. This article has 1455 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nrd2792)

[4. (Xie2020FGF/FGFR) Yangli Xie, Nan Su, Jing Yang, Qiaoyan Tan, Shuo Huang, Min Jin, Zhenhong Ni, Bin Zhang, Dali Zhang, Fengtao Luo, Hangang Chen, Xianding Sun, Jian Q. Feng, Huabing Qi, and Lin Chen. Fgf/fgfr signaling in health and disease. Signal Transduction and Targeted Therapy, September 2020. URL: http://dx.doi.org/10.1038/s41392-020-00222-7, doi:10.1038/s41392-020-00222-7. This article has 344 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41392-020-00222-7)

[5. (Shamsi2020FGF6) Farnaz Shamsi, Ruidan Xue, Tian Lian Huang, Morten Lundh, Yang Liu, Luiz O. Leiria, Matthew D. Lynes, Elena Kempf, Chih-Hao Wang, Satoru Sugimoto, Pasquale Nigro, Kathrin Landgraf, Tim Schulz, Yiming Li, Brice Emanuelli, Srinivas Kothakota, Lewis T. Williams, Niels Jessen, Steen Bønløkke Pedersen, Yvonne Böttcher, Matthias Blüher, Antje Körner, Laurie J. Goodyear, Moosa Mohammadi, C. Ronald Kahn, and Yu-Hua Tseng. Fgf6 and fgf9 regulate ucp1 expression independent of brown adipogenesis. Nature Communications, March 2020. URL: http://dx.doi.org/10.1038/s41467-020-15055-9, doi:10.1038/s41467-020-15055-9. This article has 72 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-020-15055-9)

[6. (Farooq2021The) Mariya Farooq, Abdul Waheed Khan, Moon Suk Kim, and Sangdun Choi. The role of fibroblast growth factor (fgf) signaling in tissue repair and regeneration. Cells, 10(11):3242, November 2021. URL: http://dx.doi.org/10.3390/cells10113242, doi:10.3390/cells10113242. This article has 74 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells10113242)

[7. (Nies2016Fibroblast) Vera J. M. Nies, Gencer Sancar, Weilin Liu, Tim van Zutphen, Dicky Struik, Ruth T. Yu, Annette R. Atkins, Ronald M. Evans, Johan W. Jonker, and Michael Robert Downes. Fibroblast growth factor signaling in metabolic regulation. Frontiers in Endocrinology, January 2016. URL: http://dx.doi.org/10.3389/fendo.2015.00193, doi:10.3389/fendo.2015.00193. This article has 47 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fendo.2015.00193)

[8. (Goutam2023Exploring) Ravi Shankar Goutam, Vijay Kumar, Unjoo Lee, and Jaebong Kim. Exploring the structural and functional diversity among fgf signals: a comparative study of human, mouse, and xenopus fgf ligands in embryonic development and cancer pathogenesis. International Journal of Molecular Sciences, 24(8):7556, April 2023. URL: http://dx.doi.org/10.3390/ijms24087556, doi:10.3390/ijms24087556. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms24087556)